Physiologically Based Pharmacokinetic Modeling to Assess the Impact of Pathophysiological Changes in Neonates: Strengths, Weaknesses, and Next Steps

Documenti analoghi

• Physiologically Based Pharmacokinetic Modeling of Vancomycin in Critically Ill Neonates: Assessing the Impact of Pathophysiological Changes
  di: Weiwei Shuai, et al.
  Pubblicazione: (2024)
• From Fragmented Data to Integrated Drug Development in Asphyxiated Neonates Undergoing Therapeutic Hypothermia
  di: Karel Allegaert, et al.
  Pubblicazione: (2025)
• Physiologically Based Pharmacokinetic Modeling of Vancomycin and its Comparison with Population Pharmacokinetic Model in Neonates
  di: Ailing Cao, et al.
  Pubblicazione: (2024)
• Physiologically Based Pharmacokinetic Modeling of Caffeine in Preterm Neonates: Influence of Renal Function and Impairment on Dosing
  di: Nolan Thomas, et al.
  Pubblicazione: (2025)
• From cradle to cane—(Dis)similarities between paediatric and geriatric clinical pharmacology: A commentary arising from the 2024 International Union of Basic and Clinical Pharmacology (IUPHAR) World Smart Medication Day
  di: Karel Allegaert, et al.
  Pubblicazione: (2025)